Invention Grant
- Patent Title: Gut microbiota and treatment of cancer
-
Application No.: US16461850Application Date: 2017-11-17
-
Publication No.: US11571446B2Publication Date: 2023-02-07
- Inventor: Yan Li , Scott Peterson , Linda Bradley , Roberto Tinoco , Ze'ev Ronai , Shiri Ashkenazi
- Applicant: Sanford Burnham Prebys Medical Discovery Institute , Technion Research & Development Foundation Ltd.
- Applicant Address: US CA La Jolla; IL Haifa
- Assignee: Sanford Burnham Prebys Medical Discovery Institute,Technion Research & Development Foundation Ltd.
- Current Assignee: Sanford Burnham Prebys Medical Discovery Institute,Technion Research & Development Foundation Ltd.
- Current Assignee Address: US CA La Jolla; IL Haifa
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2017/062257 WO 20171117
- International Announcement: WO2018/094190 WO 20180524
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A61P35/00 ; A61K31/7004 ; A61K31/7008 ; A61K31/7024 ; A61K31/733 ; A61K39/395 ; C07K16/28

Abstract:
The ubiquitin ligase, RNF5, regulates the gut microbiota composition and influences the immune checkpoint response to tumors. RNF5 deficient animals exhibit significant inhibition of tumor development as well as an altered gut microbiota composition. Methods of treating cancer by administering to a subject one or more selected bacterial species and/or one or more prebiotics that promote the growth of one or more selected bacterial species are disclosed. Also disclosed are methods of treating cancer by administering to a subject one or more selected bacterial species and/or one or more prebiotics that promote the growth of one or more selected bacterial species in combination with one or more anti-cancer agents.
Information query